Taking into consideration that impaired adiponectin signaling is a common consequence of obesity and this adipokine prevents some malignant metabolic phenotypes of tumor cells, adiponectin mimic therapy might be another therapeutic strategy for obesity-linked cancer. This evidence concerns the gene ADIPOQ and obesity disorder.